218 related articles for article (PubMed ID: 26390015)
21. Identification of N,N-arylalkyl-picolinamide derivatives targeting the RNA-binding protein HuR, by combining biophysical fragment-screening and molecular hybridization.
Della Volpe S; Linciano P; Listro R; Tumminelli E; Amadio M; Bonomo I; Elgaher WAM; Adam S; Hirsch AKH; Boeckler FM; Vasile F; Rossi D; Collina S
Bioorg Chem; 2021 Nov; 116():105305. PubMed ID: 34482166
[TBL] [Abstract][Full Text] [Related]
22. Suramin, screened from an approved drug library, inhibits HuR functions and attenuates malignant phenotype of oral cancer cells.
Kakuguchi W; Nomura T; Kitamura T; Otsuguro S; Matsushita K; Sakaitani M; Maenaka K; Tei K
Cancer Med; 2018 Dec; 7(12):6269-6280. PubMed ID: 30449075
[TBL] [Abstract][Full Text] [Related]
23. Low Molecular Weight Inhibitors Targeting the RNA-Binding Protein HuR.
Joseph BP; Weber V; Knüpfer L; Giorgetti A; Alfonso-Prieto M; Krauß S; Carloni P; Rossetti G
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37685931
[TBL] [Abstract][Full Text] [Related]
24. NMR-based platform for fragment-based lead discovery used in screening BRD4-targeted compounds.
Yu JL; Chen TT; Zhou C; Lian FL; Tang XL; Wen Y; Shen JK; Xu YC; Xiong B; Zhang NX
Acta Pharmacol Sin; 2016 Jul; 37(7):984-93. PubMed ID: 27238211
[TBL] [Abstract][Full Text] [Related]
25. A 1536-well fluorescence polarization assay to screen for modulators of the MUSASHI family of RNA-binding proteins.
Minuesa G; Antczak C; Shum D; Radu C; Bhinder B; Li Y; Djaballah H; Kharas MG
Comb Chem High Throughput Screen; 2014; 17(7):596-609. PubMed ID: 24912481
[TBL] [Abstract][Full Text] [Related]
26. mRNA openers and closers: modulating AU-rich element-controlled mRNA stability by a molecular switch in mRNA secondary structure.
Meisner NC; Hackermüller J; Uhl V; Aszódi A; Jaritz M; Auer M
Chembiochem; 2004 Oct; 5(10):1432-47. PubMed ID: 15457527
[TBL] [Abstract][Full Text] [Related]
27. Implementation of a 220,000-compound HCS campaign to identify disruptors of the interaction between p53 and hDM2 and characterization of the confirmed hits.
Dudgeon DD; Shinde S; Hua Y; Shun TY; Lazo JS; Strock CJ; Giuliano KA; Taylor DL; Johnston PA; Johnston PA
J Biomol Screen; 2010 Aug; 15(7):766-82. PubMed ID: 20639499
[TBL] [Abstract][Full Text] [Related]
28. High-Throughput Screening and Triage Assays Identify Small Molecules Targeting c-MYC in Cancer Cells.
Kallal LA; Waszkiewicz A; Jaworski JP; Della Pietra A; Berrodin T; Brady P; Jurewicz AJ; Zeng X; Payne L; Medina JR; Doepner-Buser C; Mangatt B
SLAS Discov; 2021 Feb; 26(2):216-229. PubMed ID: 33482073
[TBL] [Abstract][Full Text] [Related]
29. Discovery of the first small-molecule CsrA-RNA interaction inhibitors using biophysical screening technologies.
Maurer CK; Fruth M; Empting M; Avrutina O; Hoßmann J; Nadmid S; Gorges J; Herrmann J; Kazmaier U; Dersch P; Müller R; Hartmann RW
Future Med Chem; 2016 Jun; 8(9):931-47. PubMed ID: 27253623
[TBL] [Abstract][Full Text] [Related]
30. Identification of influenza virus inhibitors targeting NS1A utilizing fluorescence polarization-based high-throughput assay.
Cho EJ; Xia S; Ma LC; Robertus J; Krug RM; Anslyn EV; Montelione GT; Ellington AD
J Biomol Screen; 2012 Apr; 17(4):448-59. PubMed ID: 22223052
[TBL] [Abstract][Full Text] [Related]
31. SCAN--a high-throughput assay for detecting small molecule binding to RNA targets.
Baugh C; Wang S; Li B; Appleman JR; Thompson PA
J Biomol Screen; 2009 Mar; 14(3):219-29. PubMed ID: 19211778
[TBL] [Abstract][Full Text] [Related]
32. Development of high-throughput assays based on fluorescence polarization for inhibitors of the polo-box domains of polo-like kinases 2 and 3.
Reindl W; Gräber M; Strebhardt K; Berg T
Anal Biochem; 2009 Dec; 395(2):189-94. PubMed ID: 19716361
[TBL] [Abstract][Full Text] [Related]
33. Identification of NOD2 as a novel target of RNA-binding protein HuR: evidence from NADPH oxidase-mediated HuR signaling in diabetic nephropathy.
Shang J; Wan Q; Wang X; Duan Y; Wang Z; Wei X; Zhang Y; Wang H; Wang R; Yi F
Free Radic Biol Med; 2015 Feb; 79():217-27. PubMed ID: 25528059
[TBL] [Abstract][Full Text] [Related]
34. Aptamer Displacement Screen for Flaviviral RNA Methyltransferase Inhibitors.
Falk SP; Weisblum B
J Biomol Screen; 2014 Sep; 19(8):1147-53. PubMed ID: 24793430
[TBL] [Abstract][Full Text] [Related]
35. Exploration of ligand binding modes towards the identification of compounds targeting HuR: a combined STD-NMR and Molecular Modelling approach.
Vasile F; Della Volpe S; Ambrosio FA; Costa G; Unver MY; Zucal C; Rossi D; Martino E; Provenzani A; Hirsch AKH; Alcaro S; Potenza D; Collina S
Sci Rep; 2018 Sep; 8(1):13780. PubMed ID: 30214075
[TBL] [Abstract][Full Text] [Related]
36. Targeting the HuR Oncogenic Role with a New Class of Cytoplasmic Dimerization Inhibitors.
Filippova N; Yang X; Ananthan S; Calano J; Pathak V; Bratton L; Vekariya RH; Zhang S; Ofori E; Hayward EN; Namkoong D; Crossman DK; Crowley MR; King PH; Mobley J; Nabors LB
Cancer Res; 2021 Apr; 81(8):2220-2233. PubMed ID: 33602784
[TBL] [Abstract][Full Text] [Related]
37. Target immobilization as a strategy for NMR-based fragment screening: comparison of TINS, STD, and SPR for fragment hit identification.
Kobayashi M; Retra K; Figaroa F; Hollander JG; Ab E; Heetebrij RJ; Irth H; Siegal G
J Biomol Screen; 2010 Sep; 15(8):978-89. PubMed ID: 20817886
[TBL] [Abstract][Full Text] [Related]
38. Development of filtration-based time-resolved fluorescence assay for the high-throughput screening of urotensin II receptor antagonist.
Oh KS; Lee S; Lee BH
Assay Drug Dev Technol; 2011 Oct; 9(5):514-21. PubMed ID: 21561377
[TBL] [Abstract][Full Text] [Related]
39. The structure of the ARE-binding domains of Hu antigen R (HuR) undergoes conformational changes during RNA binding.
Wang H; Zeng F; Liu Q; Liu H; Liu Z; Niu L; Teng M; Li X
Acta Crystallogr D Biol Crystallogr; 2013 Mar; 69(Pt 3):373-80. PubMed ID: 23519412
[TBL] [Abstract][Full Text] [Related]
40. Posttranscriptional Regulation of the Inflammatory Marker C-Reactive Protein by the RNA-Binding Protein HuR and MicroRNA 637.
Kim Y; Noren Hooten N; Dluzen DF; Martindale JL; Gorospe M; Evans MK
Mol Cell Biol; 2015 Dec; 35(24):4212-21. PubMed ID: 26438598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
